IRCT20200413047053N1招募中2 期
Evaluation the effect of asafoetida on coronavirus outpatients: A randomized, double-blind, placebo-controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •lymphopenia
- •CRP positive
排除标准
- •Sensitivity to asafoetida and it derivatives
- •Patients with hepatic disfunction
- •Patients with renal disfunction
- •Patients with respiratory disorders
- •Patients who take cytotoxic or corticosteroid drugs
- •Nursing women
- •pregnant women
研究者
相似试验
招募中
2 期
ANIF1 effect on COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20190727044343N3Mazandaran University of Medical Sceinces60
进行中（未招募）
1 期
Effect of Camostat Mesilate on individuals with COVID-19 infectio2019-nCoV acute respiratory diseaseMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001200-42-DKDepartment of Infecitous Diseases, Aarhus University Hospital580
已完成
Unknown
Clinical Performance of Coronavirus (COVID-19) Antigen Rapid Test Kits for the detection of COVID-19 variants in clinical samples from people aged 7-75 yearsACTRN12623000811606Koi Biotech Pty Ltd60
已完成
不适用
Resarch of the effect of antiviral drugs on the suppression of COVID-19 persistent symptomsCOVID-19JPRN-UMIN000048380agasaki University382
撤回
2 期
Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19Covid 19 PositiveCorona Virus InfectionNCT04387240Princess Nourah Bint Abdulrahman University